Association between plasma venetoclax trough levels and serum C-reactive protein levels in patients with acute myeloid leukemia treated with venetoclax plus azacitidine.

Authors :: Yasu T
Gando Y
Shirota M
Kosugi N
Kobayashi M
Source :: Leukemia & lymphoma [Leuk Lymphoma] 2024 Jan; Vol. 65 (1), pp. 128-131. Date of Electronic Publication: 2024 Jan 10.
Publication Year :: 2024

Subjects :: Humans
Azacitidine therapeutic use
Bridged Bicyclo Compounds, Heterocyclic adverse effects
Antineoplastic Combined Chemotherapy Protocols adverse effects
C-Reactive Protein
Leukemia, Myeloid, Acute diagnosis
Leukemia, Myeloid, Acute drug therapy
Leukemia, Myeloid, Acute chemically induced
Sulfonamides

Full Text Access

Tools